Spectrotype analysis and clonal characteristics of human anti-Gal alpha1-3Gal antibodies

Xenotransplantation

Volumn 9, Issue 4, 2002, Pages 252-259

  Tinguely, Caroline ^a   Schaller, Monica ^a   Carrel, Thierry ^a   Nydegger, Urs E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Anti Gal; Ig spectrotypes; VH gene usage

Indexed keywords

CELL ADHESION MOLECULE; GALACTOSE ALPHA 1,3 GALACTOSE ANTIBODY; GALACTOSYLGALACTOSE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GENE AMPLIFICATION; GENE EXPRESSION; GENE STRUCTURE; GENETIC HETEROGENEITY; GERM LINE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOGLOBULIN GENE; ISOELECTRIC FOCUSING; ISOELECTRIC POINT; MULTIGENE FAMILY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOMATIC HYPERMUTATION; SOMATIC MUTATION; SPECTROTYPE ANALYSIS; STRUCTURE ANALYSIS; SWINE; XENOTRANSPLANTATION;

ANTIBODIES, ANTI-IDIOTYPIC; BASE SEQUENCE; BLOOD DONORS; CLONAL ANERGY; DISACCHARIDES; DNA PRIMERS; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN M; IMMUNOGLOBULIN VARIABLE REGION; POLYMERASE CHAIN REACTION;

EID: 0036665030     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3089.2002.00148.x     Document Type: Article

References (34)

1. GALILI U, WANG L, LATEMPLE DC, RADIC MZ. The natural anti-Gal antibody. Subcell Biochem 1999; 32: 79.
2. GALILI U, MACHER BA, BUEHLER J, SHOHET SB. Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1-3)-linked galactose residues. J Exp Med 1985; 162: 573.
3. AUCHINCLOSS H JR, SACHS DH. Xenogeneic transplantation. Annu Rev Immunol 1998; 16: 433.
4. DOENZ U, NYDEGGER UE, KUENG A, CARREL T, MOHACSI P. Anti-Gal alpha 1 Gal IgM/IgG antibody levels in infants. do they have a clinical relevance in pediatric xenotransplantation? Intern Soc Heart Lung Transpl 2000; 19: 1108.
5. OCHSENBEIN AF, FEHR T, LUTZ C et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999; 286: 2156.
6. KALINKE UEMB, ERNST B, OXENIUS A et al. The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus (VSV). Immunity 1996; 5: 639.
7. GELLERT M. Recent advances in understanding V(D)J recombination. Adv Immunol 1997; 64: 39.
8. FUGMANN SD, LEE AI, SHOKETT PE, VILLEY IJ, SCHATZ DG. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu Rev Immunol 2000; 18: 495.
9. HASSARIN A, GOLUB R, LEWIS SM, Wu JE. Evolution of the recombination signal sequences in the Ig heavy-chain variable region locus of mammals. Proc Nat Acad Sci USA 2000; 97: 11415.
10. CRAMER DV, WU GD, KEARNS-JONKER M et al. The humoral response to xenografts is controlled by a restricted repertoire of immunoglobulin VH genes. Transplantation 1998; 66: 1375.
11. KEARNS-JONKER M, SWENSSON J, GHIUZELI C et al. The human antibody response to porcine xenoantigens is encoded by IGHV3 and IGHV3-74 IgVH germline progenitors. J Immunol 1999; 163: 4399.
12. MCKANE W, LEE J, PRESTON R et al. Polymorphism in the human anti-pig natural antibody repertoire: implications for antigen-specific immunoadsorption. Transplantation 1998; 66: 626.
13. WANG L, RADIC MZ, GALILI U. Human anti-Gal heavy chain genes. Preferential use of VH3 and the presence of somatic mutations. J Immunol 1995; 155: 1276.
14. RIEBEN R, VON ALLMEN E, KORCHAGINA EY et al. Detection, immunoabsorption, and inhibition of cytotoxic activity of anti-αGal antibodies using newly developed substances with synthetic Gal α1 Gal disaccharide epitopes. Xenotransplantation 1995; 2: 98.
15. KANTOR AB, MERRILL CE, HILLSON JL. Construction of cDNA from single unstimulated mouse B lymphocytes: method and application to the study of expressed antibody repertoires in FACS-sorted Murine B cell subsets. In: WEIR DM, ed. Handbook of Experimental Immunology, Vol. 1, Immunochemistry and Molecular Immunology. Oxford: Blackwell, 1997.
16. WILLIAMSON AR. Isoelectric focussing analysis of immunoglobulins. In: WEIR DM, ed. Handbook of Experimental Immunology, Vol. 1. Immunochemistry and Molecular Immunology. Oxford: Blackwell, 1997.
17. RIEBEN R, FRAUENFELDER A, NYDEGGER UE. Spectrotype analysis of human ABO antibodies: evidence for different clonal heterogeneity of IgM, IgG, and IgA antibody populations. Vox Sang 1996; 70: 104.
18. AVRAMEAS S. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today 1991; 12: 154.
19. AVRAMEAS S, TERNYNCK T. Natural autoantibodies: the other side of the immune system. Res Immunol 1995; 146: 235.
20. LACROIX-DESMAZES S, KAVERI SV, MOUTHON L et al. Selfreactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Meth 1998; 216: 117.
21. MURALI-KRISHNA K, AHMED R. Cutting edge: naive T cells masquerading as memory cells. J Immunol 2000; 165: 1733.
22. RIEBEN R, FRAUENFELDER A, NYDEGGER UE. Naturally occurring ABO antibodies: long-term stable, individually distinct anti-A IgG spectrotypes. Eur J Immunol 1992; 22: 2129.
23. AWDEH ZL, WILLIAMSON AR, ASKONAS BA. One cell - one immunoglobulin. Origin of limited heterogeneity of myeloma proteins. Biochem J 1970; 116: 241.
24. DAVIDKOVA G, PETTERSSON S, HOLMBERG D, LUNDKVIST I. Selective usage of VH genes in adult human B lymphocyte repertoires. Scand J Immunol 1997; 45: 62.
25. BUONOMANO R, TINGUELY C, RIEBEN R, MOHACSI PJ, NYDEGGER UE. Quantitation and characterization of anti-GalalphalGal antibodies in sera of 200 healthy persons. Xenotransplantation 1999; 6: 173.
26. KOREN E, NEETHLING FA, YE, Y et al. Heterogeneity of preformed human antipig xenogeneic antibodies. Transplant Proc 1992; 24: 598.
27. PARKER W, LATEEF J, EVERETT ML, PLATT JL. Specificity of xenoreactive anti-Gal alpha 1Gal IgM for alpha-galactosyl ligands. Glycobiology 1996; 6: 499.
28. ANDRIS JS, BRODEUR BR, CAPRA JD. Molecular characterization of human antibodies to bacterial antigens: utilization of the less frequently expressed VH2 and VH6 heavy chain variable region gene families. Mol Immunol 1993; 30: 1601.
29. WANG L, RADIC MZ, SIEGEL D et al. Cloning of anti-Gal Fabs from combinatorial phage display libraries: structural analysis and comparison of Fab expression in pComb3H and pComb8 phage. Mol Immunol 1997; 34: 609.
30. GAULI U. Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody. Springer Semin Immunopathol 1993; 15: 155.
31. GALILI U, RACHMILEWITZ EA, PELEG A, FLECHNER I. A unique natural human IgG antibody with anti-alphagalactosyl specificity. J Exp Med 1984; 160: 1519.
32. GALILI U, MANDRELL RE, HAMADEH RM, SHOHET SB, GRIFFISS JM. Interaction between human natural antialpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun 1988; 56: 1730.
33. HAMADEH RM, JARVIS GA, GALILI U et al. Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces. J Clin Invest 1992; 89: 1223.
34. GERBER B, TINGUELY C, BOVIN NV et al. Differences between synthetic oligosaccharide immunoabsorbents in depletion capacity for xenoreactive anti-Galα1Gal antibodies from human serum. Xenotranplantation 2001; 8: 106.